Drug Type ASO |
Synonyms- |
Target |
Action inhibitors |
Mechanism ACTA1 inhibitors(actin alpha 1, skeletal muscle inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Myotonic Dystrophy | Preclinical | United States | 01 May 2017 | |
| Myotonic Dystrophy | Preclinical | United States | 01 May 2017 |





